No increased Risk of severe Infections under Biologic Therapies in Patients with Psoriasis

被引：0
|
作者：
Sossau, D. [1 ]
Yazdi, A. S. [1 ]
机构：
[1] Univ Hautklin, Liebermeisterstr 25, D-72076 Tubingen, Germany
来源：
HAUTARZT | 2018年 / 69卷 / 07期
关键词：
D O I：
10.1007/s00105-018-4209-3
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：609 / 610
页数：2
相关论文
共 50 条
  • [1] Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis
    Yiu, Zenas Z. N.
    Exton, Lesley S.
    Jabbar-Lopez, Zarif
    Mustapa, M. Firouz Mohd
    Samarasekera, Eleanor J.
    Burden, A. David
    Murphy, Ruth
    Owen, Caroline M.
    Parslew, Richard
    Venning, Vanessa
    Ashcroft, Darren M.
    Griffiths, Christopher E. M.
    Smith, Catherine H.
    Warren, Richard B.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (08) : 1584 - 1591
  • [2] Biologic Therapies for Moderate to Severe Psoriasis Are Not Interchangeable
    Puig, L.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2014, 105 (05): : 483 - 486
  • [3] Opinion Survey on Persistence of Biologic Therapies in Patients with Moderate to Severe Psoriasis
    Puig, L.
    Alarcon, I.
    Sulleiro, S.
    Alfonso, S.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (08): : 690 - 693
  • [4] Risk of Serious Infections During Use of Biologic Therapies for Psoriasis: A Systematic Review
    Yiu, Zenas Z. N.
    Exton, Lesley S.
    Jabbar-Lopez, Zarif
    Mustapa, M. Firouz Mohd
    Samarasekera, Eleanor
    Burden, David
    Murphy, Ruth
    Owen, Caroline M.
    Parslew, Richard
    Venning, Vanessa
    Ashcroft, Darren M.
    Griffiths, Christopher E. M.
    Smith, Catherine H.
    Warren, Richard B.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 517 - 518
  • [5] The Status of Biologic Therapies in the Treatment of Moderate to Severe Psoriasis
    Menter, Alan
    [J]. CUTIS, 2009, 84 (04): : 14 - 24
  • [6] Biologic Therapies for Psoriasis
    de Felice, Catia
    Ardigo, Marco
    Berardesca, Enzo
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 : 62 - 64
  • [7] Patients with severe psoriasis have an increased risk of mortality
    Kurd, S. K.
    Lewis, J. L.
    Troxel, A. B.
    Margolis, D. J.
    Strom, B. L.
    Shin, D. B.
    Wang, X.
    Gelfand, J. M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S59 - S59
  • [8] Patients with severe psoriasis have an increased risk of mortality
    Kurd, S. K.
    Gelfand, J. M.
    James, L.
    Troxel, A. B.
    Margolis, D.
    Shin, D. B.
    Wang, X.
    Strom, B. L.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S27 - S27
  • [9] The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
    Furst, Daniel E.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 39 (05) : 327 - 346
  • [10] Timing of the last dose of biologic therapy and risk of postsurgical infections in patients with psoriasis
    Yiu, Z.
    Ashcroft, D.
    Evans, I.
    McElhone, K.
    Walton, S.
    Lunt, M.
    Griffiths, C.
    Warren, R.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 : 9 - 9
12345